Alembic Pharmaceuticals Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

12:07 PM, 12th Jan 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative approval for Bosutinib Tablets 400 mg.